ID   GA45A_HUMAN             Reviewed;         165 AA.
AC   P24522; Q5TCA7; Q5TCA8;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   07-APR-2021, entry version 172.
DE   RecName: Full=Growth arrest and DNA damage-inducible protein GADD45 alpha;
DE   AltName: Full=DNA damage-inducible transcript 1 protein;
DE            Short=DDIT-1;
GN   Name=GADD45A; Synonyms=DDIT1, GADD45;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1990262; DOI=10.1128/mcb.11.2.1009;
RA   Papathanasiou M.A., Kerr N.C.K., Robbins J.H., McBride O.W., Alamo I. Jr.,
RA   Barrett S.F., Hickson I.D., Fornace A.J. Jr.;
RT   "Induction by ionizing radiation of the gadd45 gene in cultured human
RT   cells: lack of mediation by protein kinase C.";
RL   Mol. Cell. Biol. 11:1009-1016(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lung;
RX   PubMed=8226988;
RA   Hollander M.C., Alamo I. Jr., Jackman J., Wang M.G., McBride O.W.,
RA   Fornace A.J. Jr.;
RT   "Analysis of the mammalian gadd45 gene and its response to DNA damage.";
RL   J. Biol. Chem. 268:24385-24393(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Bronchiolar epithelial cell;
RX   PubMed=16421274; DOI=10.1093/nar/gkj459;
RA   Zhang Y., Bhatia D., Xia H., Castranova V., Shi X., Chen F.;
RT   "Nucleolin links to arsenic-induced stabilization of GADD45alpha mRNA.";
RL   Nucleic Acids Res. 34:485-495(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH GADD45GIP1.
RC   TISSUE=Colon carcinoma;
RX   PubMed=12716909; DOI=10.1074/jbc.m212835200;
RA   Chung H.K., Yi Y.-W., Jung N.-C., Kim D., Suh J.M., Kim H., Park K.C.,
RA   Song J.H., Kim D.W., Hwang E.S., Yoon S.-H., Bae Y.-S., Kim J.M., Bae I.,
RA   Shong M.;
RT   "CR6-interacting factor 1 interacts with Gadd45 family proteins and
RT   modulates the cell cycle.";
RL   J. Biol. Chem. 278:28079-28088(2003).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PCNA.
RX   PubMed=7973727; DOI=10.1126/science.7973727;
RA   Smith M.L., Chen I.-T., Zhan Q., Bae I., Chen C.-Y., Gilmer T.M.,
RA   Kastan M.B., O'Connor P.M., Fornace A.J. Jr.;
RT   "Interaction of the p53-regulated protein Gadd45 with proliferating cell
RT   nuclear antigen.";
RL   Science 266:1376-1380(1994).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   STRUCTURE BY NMR, SUBUNIT, INTERACTION WITH PCNA AND AURKA, AND MUTAGENESIS
RP   OF LEU-77.
RX   PubMed=20460379; DOI=10.1074/jbc.m109.069344;
RA   Sanchez R., Pantoja-Uceda D., Prieto J., Diercks T., Marcaida M.J.,
RA   Montoya G., Campos-Olivas R., Blanco F.J.;
RT   "Solution structure of human growth arrest and DNA damage 45alpha
RT   (Gadd45alpha) and its interactions with proliferating cell nuclear antigen
RT   (PCNA) and Aurora A kinase.";
RL   J. Biol. Chem. 285:22196-22201(2010).
CC   -!- FUNCTION: In T-cells, functions as a regulator of p38 MAPKs by
CC       inhibiting p88 phosphorylation and activity (By similarity). Might
CC       affect PCNA interaction with some CDK (cell division protein kinase)
CC       complexes; stimulates DNA excision repair in vitro and inhibits entry
CC       of cells into S phase. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with MAPK14 (By similarity). Predominantly monomeric
CC       but also forms dimers and other oligomers as concentration increases.
CC       Interacts with GADD45GIP1. Interacts weakly with PCNA. Interacts with
CC       AURKA, likely to compete with dimerization. {ECO:0000250,
CC       ECO:0000269|PubMed:12716909, ECO:0000269|PubMed:20460379,
CC       ECO:0000269|PubMed:7973727}.
CC   -!- INTERACTION:
CC       P24522; Q9GZX7: AICDA; NbExp=5; IntAct=EBI-448167, EBI-3834328;
CC       P24522; Q92600-3: CNOT9; NbExp=5; IntAct=EBI-448167, EBI-12907584;
CC       P24522; Q13561: DCTN2; NbExp=7; IntAct=EBI-448167, EBI-715074;
CC       P24522; Q14204: DYNC1H1; NbExp=3; IntAct=EBI-448167, EBI-356015;
CC       P24522; P28715: ERCC5; NbExp=2; IntAct=EBI-448167, EBI-765885;
CC       P24522; Q8TAE8: GADD45GIP1; NbExp=3; IntAct=EBI-448167, EBI-372506;
CC       P24522; Q92876: KLK6; NbExp=3; IntAct=EBI-448167, EBI-2432309;
CC       P24522; P80303: NUCB2; NbExp=2; IntAct=EBI-448167, EBI-2296670;
CC       P24522; Q9HBI0: PARVG; NbExp=3; IntAct=EBI-448167, EBI-3921217;
CC       P24522; Q9Y371: SH3GLB1; NbExp=2; IntAct=EBI-448167, EBI-2623095;
CC       P24522; Q13569: TDG; NbExp=3; IntAct=EBI-448167, EBI-348333;
CC       P24522; Q9WVE0: Aicda; Xeno; NbExp=3; IntAct=EBI-448167, EBI-3835567;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:7973727}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P24522-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P24522-2; Sequence=VSP_042523;
CC   -!- INDUCTION: By UV irradiation, X-rays, growth arrest and alkylating
CC       agents. The induction is mediated by some kinase(s) other than PKC.
CC   -!- SIMILARITY: Belongs to the GADD45 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gadd45a/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=GADD45A entry;
CC       URL="https://en.wikipedia.org/wiki/GADD45A";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L24498; AAA72045.1; -; Genomic_DNA.
DR   EMBL; M60974; AAA35863.1; -; mRNA.
DR   EMBL; AY135686; AAM88884.1; -; Genomic_DNA.
DR   EMBL; DQ008445; AAY25021.1; -; mRNA.
DR   EMBL; AK314991; BAG37487.1; -; mRNA.
DR   EMBL; AL136120; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06487.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06488.1; -; Genomic_DNA.
DR   EMBL; BC011757; AAH11757.1; -; mRNA.
DR   CCDS; CCDS55605.1; -. [P24522-2]
DR   CCDS; CCDS640.1; -. [P24522-1]
DR   PIR; A39617; A39617.
DR   RefSeq; NP_001186670.1; NM_001199741.1. [P24522-2]
DR   RefSeq; NP_001186671.1; NM_001199742.1.
DR   RefSeq; NP_001915.1; NM_001924.3. [P24522-1]
DR   PDB; 2KG4; NMR; -; A=1-165.
DR   PDBsum; 2KG4; -.
DR   BMRB; P24522; -.
DR   SMR; P24522; -.
DR   BioGRID; 108014; 95.
DR   CORUM; P24522; -.
DR   DIP; DIP-24217N; -.
DR   IntAct; P24522; 65.
DR   MINT; P24522; -.
DR   STRING; 9606.ENSP00000360025; -.
DR   iPTMnet; P24522; -.
DR   PhosphoSitePlus; P24522; -.
DR   BioMuta; GADD45A; -.
DR   DMDM; 120751; -.
DR   EPD; P24522; -.
DR   MassIVE; P24522; -.
DR   PaxDb; P24522; -.
DR   PeptideAtlas; P24522; -.
DR   PRIDE; P24522; -.
DR   ProteomicsDB; 54209; -. [P24522-1]
DR   ProteomicsDB; 54210; -. [P24522-2]
DR   Antibodypedia; 33411; 411 antibodies.
DR   DNASU; 1647; -.
DR   Ensembl; ENST00000370985; ENSP00000360024; ENSG00000116717. [P24522-2]
DR   Ensembl; ENST00000370986; ENSP00000360025; ENSG00000116717. [P24522-1]
DR   GeneID; 1647; -.
DR   KEGG; hsa:1647; -.
DR   UCSC; uc001ddz.3; human. [P24522-1]
DR   CTD; 1647; -.
DR   DisGeNET; 1647; -.
DR   GeneCards; GADD45A; -.
DR   HGNC; HGNC:4095; GADD45A.
DR   HPA; ENSG00000116717; Tissue enhanced (kidney, skeletal muscle).
DR   MIM; 126335; gene.
DR   neXtProt; NX_P24522; -.
DR   OpenTargets; ENSG00000116717; -.
DR   PharmGKB; PA28510; -.
DR   VEuPathDB; HostDB:ENSG00000116717.11; -.
DR   eggNOG; ENOG502RY8P; Eukaryota.
DR   GeneTree; ENSGT00950000182964; -.
DR   HOGENOM; CLU_118164_0_0_1; -.
DR   InParanoid; P24522; -.
DR   OMA; PPTDLHC; -.
DR   OrthoDB; 1517160at2759; -.
DR   PhylomeDB; P24522; -.
DR   TreeFam; TF300196; -.
DR   PathwayCommons; P24522; -.
DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-HSA-9617828; FOXO-mediated transcription of cell cycle genes.
DR   SIGNOR; P24522; -.
DR   BioGRID-ORCS; 1647; 8 hits in 1004 CRISPR screens.
DR   ChiTaRS; GADD45A; human.
DR   EvolutionaryTrace; P24522; -.
DR   GeneWiki; GADD45A; -.
DR   GenomeRNAi; 1647; -.
DR   Pharos; P24522; Tbio.
DR   PRO; PR:P24522; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P24522; protein.
DR   Bgee; ENSG00000116717; Expressed in quadriceps femoris and 241 other tissues.
DR   ExpressionAtlas; P24522; baseline and differential.
DR   Genevisible; P24522; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:CAFA.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0047485; F:protein N-terminus binding; IDA:CAFA.
DR   GO; GO:0000185; P:activation of MAPKKK activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0007098; P:centrosome cycle; IEA:Ensembl.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0071850; P:mitotic cell cycle arrest; IDA:CACAO.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IMP:CACAO.
DR   GO; GO:0033140; P:negative regulation of peptidyl-serine phosphorylation of STAT protein; IMP:CACAO.
DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IMP:CACAO.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:CACAO.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; IBA:GO_Central.
DR   GO; GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0042770; P:signal transduction in response to DNA damage; IMP:BHF-UCL.
DR   DisProt; DP00704; -.
DR   Gene3D; 3.30.1330.30; -; 1.
DR   InterPro; IPR024824; GADD45.
DR   InterPro; IPR029064; L30e-like.
DR   InterPro; IPR004038; Ribosomal_L7Ae/L30e/S12e/Gad45.
DR   PANTHER; PTHR10411; PTHR10411; 1.
DR   Pfam; PF01248; Ribosomal_L7Ae; 1.
DR   SUPFAM; SSF55315; SSF55315; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; DNA damage; Growth arrest;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN           1..165
FT                   /note="Growth arrest and DNA damage-inducible protein
FT                   GADD45 alpha"
FT                   /id="PRO_0000148331"
FT   REGION          1..16
FT                   /note="Intrinsically disordered"
FT   REGION          105..118
FT                   /note="Intrinsically disordered"
FT   MOD_RES         2
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         15..49
FT                   /note="RMDKVGDALEEVLSKALSQRTITVGVYEAAKLLNV -> S (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:16421274"
FT                   /id="VSP_042523"
FT   MUTAGEN         77
FT                   /note="L->E: Abolishes dimerization."
FT                   /evidence="ECO:0000269|PubMed:20460379"
FT   HELIX           16..33
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   STRAND          36..38
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   HELIX           40..42
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   HELIX           43..49
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   TURN            51..53
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   STRAND          54..60
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   HELIX           64..67
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   HELIX           69..84
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   STRAND          89..93
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   HELIX           95..104
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   TURN            105..107
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   STRAND          124..128
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   HELIX           138..151
FT                   /evidence="ECO:0007744|PDB:2KG4"
FT   TURN            152..154
FT                   /evidence="ECO:0007744|PDB:2KG4"
SQ   SEQUENCE   165 AA;  18336 MW;  F2ADC183F6C0F064 CRC64;
     MTLEEFSAGE QKTERMDKVG DALEEVLSKA LSQRTITVGV YEAAKLLNVD PDNVVLCLLA
     ADEDDDRDVA LQIHFTLIQA FCCENDINIL RVSNPGRLAE LLLLETDAGP AASEGAEQPP
     DLHCVLVTNP HSSQWKDPAL SQLICFCRES RYMDQWVPVI NLPER
//
